Loading insider details...
Beta
Latest Form 4 (May 20, 2026): Grant/Award of 55,150 LRMR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 20, 2026 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 55,150 | n/a |
| May 14, 2025 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 19,000 | n/a |
| Apr 18, 2025 | BiomX Inc. (PHGE) | Grant/Award | 17,600 | n/a |
| Jul 15, 2024 | BiomX Inc. (PHGE) | Grant/Award | 264,000 | n/a |
| May 31, 2024 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 19,000 | n/a |
| May 11, 2023 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 8,300 | n/a |
| May 13, 2022 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 8,300 | n/a |
| May 17, 2021 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 8,300 | n/a |
| Sep 30, 2020 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 16,600 | n/a |